Skip to content

A Study on Ayurvedic Treatment of Hypertension Using Mansyadi Kwatha and Ashwagandha churna.

Evaluation on etio-pathogenesis of Hypertension in Ayurvedic parlance and its management with Mansyadi Kwatha and Ashwagandha churna. - NIL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106784
Enrollment
60
Registered
2026-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I679- Cerebrovascular disease, unspecified

Interventions

None listed

Sponsors

Chandra Shekhar Singh Ayurved Chikitsalaya evam Shodh Kedra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Criteria for the selection of the patients will be chiefly based on the criteria suggested by WHO and JNC-VII. Known cases of Stage-1, hypertension. Willing to participate in the study and informed consent

Exclusion criteria

Exclusion criteria: Patients suffering from hypertension along with I.H.D., C.H.D., C.A.D., coarctation of aorta Renal failure Endocrine diseases

Design outcomes

Primary

MeasureTime frame
Subjective Parameter: Lakshana: Diastolic B.P., Systolic B.P., Akshhirag, Raktapitta, Santapa, Shirahashoola, Klama, Arati, Bhrama, Nidra, Tandra, Mada, Buddhi Sanmoha, Tamaha Darshana, Krodha Prachurata Objective ParameterTimepoint: 3 months

Secondary

MeasureTime frame
Subjective Parameter: Lakshana: Diastolic B.P., Systolic B.P., Akshhirag, Raktapitta, Santapa, Shirahashoola, Klama, Arati, Bhrama, Nidra, Tandra, Mada, Buddhi Sanmoha, Tamaha Darshana, Krodha Prachurata Objective ParameterTimepoint: 3 Months

Countries

India

Contacts

Public ContactProf Dr Satya Narayan Singh

Chandra Shekhar Singh Ayurvedic Sansthan

aprajitdev786@gmail.com8269754517

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026